Lifeline Cell Technology

Lifeline Cell Technology, (www.lifelinecelltech.com), a wholly-owned subsidiary of International Stem Cell Corporation (ISCO) develops manufactures and markets high-quality human primary cells, stem cells, media and reagents for sale to pharmaceutical, academic and government scientists. The company’s management pioneered the development of the normal human cell culture market through the creation of Clonetics® Corporation in the 1980s and has over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales of human cell culture products.

Lifeline is aggressively introducing new human primary and stem cell products and building a world-class technical service department to serve the needs of the research market. The company’s human cell culture products consist of frozen human cells and optimized media. Serum-free, low-serum or animal-free cell systems are available that eliminate the need for scientists to create their own media or try to adapt “off the shelf” products to match the nutritional needs of specific cell types. Lifeline also develops and manufactures custom cells and media. Strict quality control provides high levels of consistency and standardization. Lifeline’s products include human cells from the skin, cardiovascular system (including smooth muscle) and specific organs including kidney, prostate and lungs. The company also provides skin models for toxicity testing.

Products are provided in recyclable containers and shipped in biodegradable packaging under appropriate temperatures. Lifeline’s products are distributed in the US and Europe.

For more information, please click here www.lifelinecelltech.com